Brand And Generic Opioid Makers Agree: FDA Should Issue Guidance On Tamper Resistance
This article was originally published in The Pink Sheet Daily
Executive Summary
But Purdue and Teva disagree on the key question of whether a generic of a tamper-resistant analgesic must have the same dosage form as the reference-listed brand-name drug.